Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

GlaxoSmithKline Buys Back 1.3 Million Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/04/2012 | 06:28pm CEST

GlaxoSmithKline PLC (>> GlaxoSmithKline plc) said Friday it has purchased 1,300,000 ordinary shares to be held in treasury.

MAIN FACTS:

-Highest price paid: 1455 pence per share.

-Lowest price paid: 1425 pence per share.

-Shares at 1610 GMT down 1%, at 1427 pence, valuing the company at GBP72 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; [email protected]

Stocks mentioned in the article : GlaxoSmithKline plc, GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
04/28 GLAXOSMITHKLINE : Uni in Pounds 7.9m boost
04/28 GLAXOSMITHKLINE : Blockbuster drugs will lead sales bonanza at pounds sterling 8..
04/28 GLAXOSMITHKLINE : GSK Consumer Healthcare South Asia Head calls on Health Minist..
04/27 GLAXOSMITHKLINE : Studies from GlaxoSmithKline plc Describe New Findings in Immu..
04/27 GLAXOSMITHKLINE : Researchers from GlaxoSmithKline plc Describe Findings in Mult..
04/27 GLAXOSMITHKLINE : Report Summarizes Asthma Study Findings from GlaxoSmithKline p..
04/27 GLAXOSMITHKLINE : Studies from GlaxoSmithKline plc Describe New Findings in Mono..
04/27 GLAXOSMITHKLINE : Researchers from GlaxoSmithKline plc Report Findings in Clinic..
04/27DJGLAXOSMITHKLINE : New Glaxo CEO Seeks Tighter Drug Focus -- WSJ
04/26 New GlaxoSmithKline CEO wants fewer, bigger new drug launches
More news
Sector news : Pharmaceuticals - NEC
04/30DJPFIZER : Drug Makers Take Page From Hollywood to Spread the Risk
04/28DJBRISTOL MYERS SQUIBB : China Approves Bristol-Myers Dual-Drug Hepatitis C Treatm..
04/28DJBRISTOL MYERS SQUIBB : China Approves Bristol-Myers Squibb's Dual-Drug Hepatitis..
04/28 REGENERON PHARMACEUTICALS : Sanofi beats profit forecasts, upbeat on prospects f..
04/28DJSanofi 1st-Quarter Net Profit Rises on Sale of Animal-Health Unit
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
04/27 GLAXOSMITHKLINE Q1 2017 : Mixed Signals For Investors
04/26 GLAXOSMITHKLINE : Good News, 2016's Positive Momentum Continues
04/26 GlaxoSmithKline Plc (GSK) Q1 2017 Results - Earnings Call Transcript
04/26 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2017 Update
04/26 GlaxoSmithKline Q1 revenues up 19%; non-GAAP EPS up 32%
Advertisement
Financials ( GBP)
Sales 2017 30 017 M
EBIT 2017 8 356 M
Net income 2017 4 186 M
Debt 2017 14 122 M
Yield 2017 5,16%
P/E ratio 2017 18,59
P/E ratio 2018 16,06
EV / Sales 2017 3,01x
EV / Sales 2018 2,88x
Capitalization 76 218 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 17,8  GBP
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Emma Walmsley Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Birgitte Volck Head-Research & Development
Moncef Slaoui Executive Director & Chairman-Global Vaccines
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC-0.77%98 661
JOHNSON & JOHNSON7.17%334 714
ROCHE HOLDING LTD.11.91%225 722
NOVARTIS AG3.31%202 360
PFIZER INC.4.43%201 998
MERCK & CO., INC.5.88%170 880
More Results